Immunotherapy

Harnessing the power of the immune system

Immunotherapy has transformed cancer treatment over the past decade, and the NKI has been at the forefront from the start. By integrating fundamental, translational and clinical research, we study how the immune system interacts with cancer and how this response can be strengthened. Our researchers investigate therapeutic options of myeloid immune cells modulation, explore immunotherapy in earlier disease stages, develop advanced cellular therapies, and investigate why some tumors remain resistant. The ultimate goal is clear: to make personalized immunotherapy effective for many more patients.

In the past decade, immunotherapy has given a new lease of life to part of our patients. Our research is aimed at developing immunotherapy for the majority of cancer patients.

John Haanen Theme leader Immunotherapy

Groundbreaking research into immunotherapy

In this video, physicians and researchers at the Netherlands Cancer Institute show how they are looking to improve immunotherapy. What can they do, and which questions are still left unanswered? Immunotherapy is an amazing breakthrough, You can get your own immune system to fight cancer. This works great for some patients but isn't effective for everybody just yet. The Netherlands Cancer Institute aims to increase our understanding of immunotherapy, improve treatment, and develop new types of immunotherapy through scientific research.